A recent study showed that anti-PTX3 antibodies correlated with the Birmingham Vasculitis Activity Score (BVAS) at baseline, and plasma and urinary PTX3 levels are increased in active AAV disease, especially in patients with renal involvement (14). This evidence concerns the gene PTX3 and anti-neutrophil cytoplasmic antibody-associated vasculitis.